BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: D'Agnano I, Berardi AC. Extracellular Vesicles, A Possible Theranostic Platform Strategy for Hepatocellular Carcinoma-An Overview. Cancers (Basel) 2020;12:E261. [PMID: 31973229 DOI: 10.3390/cancers12020261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Costanzi E, Simioni C, Varano G, Brenna C, Conti I, Neri LM. The Role of Extracellular Vesicles as Shuttles of RNA and Their Clinical Significance as Biomarkers in Hepatocellular Carcinoma. Genes (Basel) 2021;12:902. [PMID: 34207985 DOI: 10.3390/genes12060902] [Reference Citation Analysis]
2 Klyachko NL, Arzt CJ, Li SM, Gololobova OA, Batrakova EV. Extracellular Vesicle-Based Therapeutics: Preclinical and Clinical Investigations. Pharmaceutics 2020;12:E1171. [PMID: 33271883 DOI: 10.3390/pharmaceutics12121171] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
3 Yao M, Yang JL, Wang DF, Wang L, Chen Y, Yao DF. Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma. World J Clin Cases 2022; 10(11): 3321-3333 [DOI: 10.12998/wjcc.v10.i11.3321] [Reference Citation Analysis]
4 Haney MJ, Zhao Y, Fallon JK, Yue W, Li SM, Lentz EE, Erie D, Smith PC, Batrakova EV. Extracellular Vesicles as Drug Delivery System for Treatment of Neurodegenerative Disorders: Optimization of the Cell Source. Adv Nanobiomed Res 2021;1:2100064. [PMID: 34927169 DOI: 10.1002/anbr.202100064] [Reference Citation Analysis]
5 Słomka A, Mocan T, Wang B, Nenu I, Urban SK, Gonzales-Carmona M, Schmidt-Wolf IGH, Lukacs-Kornek V, Strassburg CP, Spârchez Z, Kornek M. EVs as Potential New Therapeutic Tool/Target in Gastrointestinal Cancer and HCC. Cancers (Basel) 2020;12:E3019. [PMID: 33080904 DOI: 10.3390/cancers12103019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
6 Ailioaie LM, Litscher G. Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E7150. [PMID: 32998270 DOI: 10.3390/ijms21197150] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Fu LY, Wang SW, Hu MY, Jiang ZL, Shen LL, Zhou YP, Guo JM, Hu YR. Circular RNAs in liver diseases: Mechanisms and therapeutic targets. Life Sci 2021;264:118707. [PMID: 33144187 DOI: 10.1016/j.lfs.2020.118707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Pandyarajan V, Govalan R, Yang JD. Risk Factors and Biomarkers for Chronic Hepatitis B Associated Hepatocellular Carcinoma. Int J Mol Sci 2021;22:E479. [PMID: 33418899 DOI: 10.3390/ijms22020479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]